Faster global financial news!
Pharmaceutical Stocks
-
Novartis's cholesterol drug Pelacarsen fails to significantly improve cardiovascular outcomes in Phase III trial; Amgen and Ionis shares decline.
Novartis announced after market close on Friday that its cholesterol drug Pelacarsen, co-developed with Ionis Pharmaceuticals, failed to significantly improve cardiovascular outcomes in late-stage cli
-
Novartis's cholesterol drug Pelacarsen fails to significantly improve cardiovascular outcomes in Phase III trial; Amgen and Ionis shares decline.
Novartis announced after market close on Friday that its cholesterol drug Pelacarsen, co-developed with Ionis Pharmaceuticals, failed to significantly improve cardiovascular outcomes in late-stage cli
- No data
Pharmaceutical Stocks
24H Trending
-
1
BTFA Coin Analysis: Banana Task Force Ape Project Background and Market Status
-
2
WZM Coin Multi-faceted Analysis: WinzoneSwap and Woozoo Music's Current Status and Trading Channels
-
3
TOKU Token: Project Analysis and Market Status
-
4
Coinbase Launches Bitcoin, Ether, and Solana Derivatives in Canada, Offering 23 Contracts with Up to 10x Leverage
-
5
Saudi Aramco's Jizan facility hit by new round of attacks.
-
6
What is JST? An Analysis of the JUST Ecosystem Token's Outlook and Value
-
7
LKT Coin: A Multifaceted Analysis – Overview and Trading Status of Projects like Lux King Tech and Locker Token
-
8
What is ARSL Coin? Analysis and Investment Considerations for Cryptocurrencies with the Same or Similar Names
-
9
Yahoo Finance: The US 10-year government bond yield hovers around 4.8%, a new high since November 2023.
-
10
HAWKTUAH Coin Trading Guide and Multi-Version Analysis: Risk Warning Under Low Liquidity
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
